医学
地尔硫卓
室上性心动过速
钙通道
观察研究
维拉帕米
腺苷
心动过速
随机对照试验
心脏病学
内科学
麻醉
钙
作者
Farrukh Ahmad,Majdi Abu Sneineh,Ravi Mangal Patel,Sai T. Reddy,Adiona Llukmani,Ayat Hashim,Dana Haddad,Domonick K Gordon
出处
期刊:Cureus
[Cureus, Inc.]
日期:2021-06-07
被引量:2
摘要
Paroxysmal supraventricular tachycardia (PSVT) is a common tachyarrhythmia, and an electrocardiogram is the best tool for making a diagnosis. If Valsalva maneuvers and carotid sinus massage do not give positive results, then the next choice is either adenosine or calcium channel blockers. At this time, adenosine is the drug of choice of treatment. Verapamil and diltiazem are the most commonly used calcium channel blockers (CCBs). This review aimed to compare the efficacy of both drugs in the treatment of PSVT. We utilized the databases PubMed Central and Medline by using keywords: "calcium channel blockers OR adenosine AND supraventricular tachycardia." In the end, we finalized 32 studies, including observational studies, literature reviews, systematic reviews/metanalysis, and randomized control trials. We included articles only in the English language and related to humans. Two authors completed the quality assessment and evaluation of bias according to specific guidelines. Only high-quality studies were included in this systematic review based on the cut-off score of seven or above. Calcium channel blockers have a longer half-life than adenosine and were previously used as the drug of choice in the treatment of PSVT. Calcium channel blockers are safe if given slowly; however, adenosine is safer and useful when an electrocardiogram is uncertain. We compared both drugs in certain aspects and found equal efficacy. Though safer, adenosine was found to have a higher cost and a higher probability of re-initiation arrhythmia compared to calcium channel blockers.
科研通智能强力驱动
Strongly Powered by AbleSci AI